13F Pro13F Pro

Integral Health Asset Management, LLC

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1773206
Institutional-grade research for retail investors

Sector Allocation

  • Healthcare96.7%$2.4B
  • Consumer Staples3.3%$79.8M

AUM History

13fpro.ai/research/fund/integral-health-asset-management-llc-1773206

Conviction and streaks

Stable · top 10 = 46.5%

From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.

RVMD$RVMDConviction hold11.5% weight · held 10 quartersINSM$INSMConviction hold7.0% weight · held 10 quartersCYTK$CYTKConviction hold5.6% weight · held 10 quartersCVS$CVSConviction hold4.7% weight · held 7 quartersEWTX$EWTXConviction hold3.3% weight · held 7 quartersCAH$CAHAccumulating+131% shares · 3 quarters runningSRRK$SRRKAccumulating+650% shares · 3 quarters runningORIC$ORICAccumulating+111% shares · 3 quarters runningINSM$INSMAccumulating+28% shares · 2 quarters runningEWTX$EWTXAccumulating+33% shares · 2 quarters runningREGN$REGNTrimming-62% shares · 2 quarters runningGKOS$GKOSTrimming-54% shares · 2 quarters runningBHVN$BHVNTrimming-53% shares · 2 quarters runningTARA$TARATrimming-33% shares · 2 quarters running

Largest positions — Q2 2026

Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.

13fpro.ai/research/fund/integral-health-asset-management-llc-1773206

Integral Health Asset Management, LLC 13F holdings — Q2 2026

$2.5B portfolio (+21.1% QoQ) · 92 holdings · Q2 2026 13F · top 10 are 47% of the stock portfolio

Includes $94.4M of put/call options ($56.2M puts, $38.2M calls), which 13F rules report at the value of the underlying shares, not the premium at risk. Stocks alone: $2.4B. Weights use the stock portfolio.

All holdings — Integral Health Asset Management, LLC (Q2 2026)

92 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.

Company
EW$EWEdwards Lifesciences Corp$56.5M+268%
RVMD$RVMDPUTRevolution Medicines, Inc.$56.2M-60%
ALHC$ALHCAlignment Healthcare, Inc.$47.6M-22%
MRK$MRKMerck & Co., Inc.$45.0M-18%
DGX$DGXQUEST DIAGNOSTICS INC$42.4M+233%
QURE$QUREuniQure N.V.$41.5M—
SRRK$SRRKScholar Rock Holding Corp$41.3M+50%
BSX$BSXBOSTON SCIENTIFIC CORP$38.4M+64%
BTSG$BTSGBrightSpring Health Services, Inc.$38.4M-56%
ABT$ABTABBOTT LABORATORIES$36.3MNew
UNH$UNHUNITEDHEALTH GROUP INC$35.3MNew
LFST$LFSTLifeStance Health Group, Inc.$32.1M-30%
NVS$NVSNOVARTIS AGadr$31.3M-20%
TNGX$TNGXTango Therapeutics, Inc.$31.3M+122%
THC$THCTENET HEALTHCARE CORP$30.9MNew

What changed in Q2 2026

Against the previous quarter's 13F: 30 new, 23 added to, 22 trimmed, 28 sold out. Share-count changes; largest moves by dollar size first.

New positions (30)

  • ABT$ABTABBOTT LABORATORIES$36.3M

    first bought this quarter

  • UNH$UNHUNITEDHEALTH GROUP INC$35.3M

    first bought this quarter

  • THC$THCTENET HEALTHCARE CORP$30.9M

    first bought this quarter

  • SYRE$SYRESpyre Therapeutics, Inc.$28.9M

    first bought this quarter

  • NVO$NVONOVO NORDISK A S$28.8M

    first bought this quarter

  • IONS$IONSCALLIONIS PHARMACEUTICALS INC$23.8M

    first bought this quarter

+24 more in the Excel export

Added to (23)

  • CVS$CVSCVS HEALTH Corp+633%

    now $113.8M · held 6+ qtrs

  • AXSM$AXSMAxsome Therapeutics, Inc.+757%

    now $73.4M · held 2 qtrs, 2 adds in a row

  • EW$EWEdwards Lifesciences Corp+268%

    now $56.5M · held 6+ qtrs

  • DGX$DGXQUEST DIAGNOSTICS INC+233%

    now $42.4M · held 5 qtrs

  • TNGX$TNGXTango Therapeutics, Inc.+122%

    now $31.3M · held 3 qtrs, 3 adds in a row

  • EWTX$EWTXEdgewise Therapeutics, Inc.+25%

    now $81.3M · held 6+ qtrs, 2 adds in a row

+17 more in the Excel export

Trimmed (22)

  • RVMD$RVMDPUTRevolution Medicines, Inc.-60%

    now $56.2M

  • BTSG$BTSGBrightSpring Health Services, Inc.-56%

    now $38.4M · held 6+ qtrs

  • REGN$REGNREGENERON PHARMACEUTICALS, INC.-53%

    now $24.9M · held 5 qtrs, 2 trims in a row

  • CNC$CNCCENTENE CORP-54%

    now $19.3M · held 4 qtrs

  • ASND$ASNDAscendis Pharma A/S-61%

    now $12.0M · held 4 qtrs

  • LFST$LFSTLifeStance Health Group, Inc.-30%

    now $32.1M · held 4 qtrs

+16 more in the Excel export

Sold out (28)

  • CYTK$CYTKCALLCYTOKINETICS INCwas $65.9M
  • AZN$AZNASTRAZENECA PLCwas $49.3M

    held 1 qtr

  • RVMD$RVMDCALLRevolution Medicines, Inc.was $48.6M
  • FMS$FMSFresenius Medical Care AGwas $17.5M

    held 7+ qtrs

  • ISRG$ISRGINTUITIVE SURGICAL INCwas $16.1M

    held 3 qtrs

  • TARS$TARSTarsus Pharmaceuticals, Inc.was $14.0M

    held 9+ qtrs

+22 more in the Excel export

Firm AUM (Form ADV): $1.9B as of 2025-12-31 · SEC IAPD

Share

Holdings by quarter

Every 13F Integral Health Asset Management, LLC has filed, 26 earlier quarters. Pick one to see what it held then.

Email me the moment this fund files its next 13FPro

Is it too late to follow Integral Health Asset Management?

Q2 2026 13F filed with the SEC on Aug 14, 2026. Prices are closing prices as of Oct 26, 2026.

Average quality of Integral Health Asset Management's top 20 holdings: 51/100 (our AI quality score, weighted by position size; 14 of the 20 are scored)

Top 10 since filing

-13.2%

Value-weighted move of the 10 largest stock positions

Turnover

23%

Last quarter; 95% over the last 4

Top 10 weight

47%

Share of the stock portfolio in its 10 largest positions

Held 4+ quarters

70%

Share of portfolio value in positions held a year or more

Highest-quality names it owns(among its 100 largest positions)

The 8 highest-scoring companies in this portfolio are a Pro feature.

How these are measured
  • Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
  • Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
  • Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q1 2025 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
  • Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
  • Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.

Portfolio Overview

Integral Health Asset Management, LLC disclosed 92 positions worth $2.5B in its Form 13F-HR for Q2 2026 — $2.4B in common stock plus $94.4M of put/call option positions (reported at underlying notional value, not premium at risk), led by $RVMD (Revolution Medicines, Inc.) at 11.5% of the equity portfolio, followed by $INSM and $CYTK. During the quarter the fund opened 30 new positions and exited 28 — including a new stake in $ABT and a full exit from $CYTK. The portfolio is most concentrated in Healthcare (96.7% of disclosed assets). All figures are sourced directly from Integral Health Asset Management, LLC’s Form 13F-HR filing with the SEC under CIK 1773206.

Funds like this

managers whose biggest positions overlap Integral Health Asset Management's
FARALLON CAPITAL MANAGEMENT LLC$21.68B 13F book · 9 shared top holdingsRVMDROIVBSXTNGXBAKER BROS. ADVISORS LP$19.96B 13F book · 7 shared top holdingsRVMDINSMRYTMROIVFirst Turn Management, LLC$934.72M 13F book · 10 shared top holdingsRVMDCYTKINSMAXSMDarwin Global Management, Ltd.$3.76B 13F book · 3 shared top holdingsRVMDINSMROIVParadigm Biocapital Advisors LP$5.34B 13F book · 5 shared top holdingsRVMDEWTXINSMTNGXRock Springs Capital Management LP$2.05B 13F book · 10 shared top holdingsRVMDRYTMINSMSRRK

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

Berkshire HathawayBridgewater AssociatesCitadel AdvisorsRenaissance TechnologiesTwo Sigma InvestmentsDE Shaw & CoMillennium ManagementAQR Capital ManagementPoint72 Asset ManagementTiger Global ManagementVanguard GroupBlackRock

to search all 8,700+ institutional filers.

AI-Powered Hedge Fund Analysis: Integral Health Asset Management, LLC

13F Pro is an AI hedge fund tracker and stock research platform. For Integral Health Asset Management, LLC (SEC CIK: 1773206), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in Integral Health Asset Management, LLC's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.